KIP PEELER: Open Payments
NPI 1649233446 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 40 payments from 13 companies in 2025. Trend: 2023 $332 · 2024 $914 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $141 |
| E.R. Squibb & Sons, L.L.C. | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| PFIZER INC. | 5 | $73 |
| Novo Nordisk Inc | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Boston Scientific Corporation | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: REPATHA, ELIQUIS, CAMZYOS, LEQVIO, Wegovy, ONPATTRO, JARDIANCE, WATCHMAN FLX.
Industry payments across PA — which companies pay providers there.
